Published Paper Details:

Biomarker is an important feature, which is quantified and evaluated objectively as an indicator of the healthful biological process, unhealthy processes, and pharmacological responses to a therapeutic intervention. These biomarkers may be circulating whole blood, serum or plasma, excretions or secretions, which are stool, urine, sputum, or nipple discharge, and are analyzed forever without invasion works. Alternatively, biomarkers are generated from tissue specimens that would, therefore, require biopsy or specific imaging for their evaluation. Inherited genetic biomarkers can be discriminated as a person's entire blood cell, sputum, or buccal cells are sequence-differences that should come from germ line DNA. Somatic genetic biomarkers are identified from mutations within DNA from tumor tissue. A marker of the presence of cancer in the body is referred to in the context of cancer as a biomarker. "In most situations, the biomarker could be a molecule released by a tumour or the body's particular response to the presence of cancer." In a summary, the biomarkers with regard to cancer application for diagnosis, prognosis, and epidemiology should be in genetics, epigenetics, proteomics, and imaging. Nonetheless, few numbers of cancer biomarkers can be highly sensitive and specific for detecting cancer. : These biomarkers are not generally ready for use due to the difficulty currently experienced in the clinical validation to improve patient's long-term survival by determining early disease detection, diagnostic, and monitoring of disease.